Drug Susceptibility Testing (DST) determines the ability of the four primary antitubercular drugs to inhibit the growth (in vitro) of Mycobacterium tuberculosis complex (MTBC) in a broth macrodilution matrix which utilizes critical concentrations of drugs tested. DST is important to the proper treatment and management of patients with tuberculosis (TB).